Akademik Veri Yönetim Sistemi
Nuclear Medicine Seminars, cilt.10, sa.1, ss.42-61, 2024 (Scopus)
The dynamic myocardial perfusion scintigraphy (MPS) single-photon emission computed tomography (SPECT), employing advancing cadmium zinc telluride (CZT) cardiac camera technology, is acknowledged as an efficacious method for appraising myocardial blood flow as an alternative to positron emission tomography (PET) agents. Combination of dynamic MPS with traditional MPS can contribute to the diagnosis and management of coronary artery disease (CAD), by improving diagnostic sensitivity and specificity of traditional MPS, as well as determination of CAD prognosis. Nevertheless, high-level evidence studies are imperative to standardize the application and assessment of dynamic MPS in clinical practice. PET perfusion imaging, in comparison to SPECT, affords superior image quality and diagnostic accuracy with reduced radiation exposure. Contemporary PET/computed tomography cameras, coupled with suitable PET radiopharmaceuticals, enable expedited imaging within a brief duration in a single session. The incorporation of blood flow measurement with quantitative evaluation serves to heighten both diagnostic accuracy and the predictive capacity for major cardiac events. Nonetheless, the utilization of dynamic PET perfusion imaging in clinical practice is considerably constrained due to its financial implications and the requisite availability of an in-house cyclotron or generator.